Table of Content

Chapter 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
Chapter 4: BRAZIL RADIOPHARMACEUTICALS MARKET, BY RADIOISOTOPE
4.1. Overview
4.1.1. Market Size and Forecast, By Radioisotope
4.2. Technetium 99m
4.3. Fluorine 18
4.4. Iodine I
4.5. Gallium 68
4.6. Others
Chapter 5: BRAZIL RADIOPHARMACEUTICALS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Cancer
5.3. Cardiology
5.4. Others
Chapter 6: BRAZIL RADIOPHARMACEUTICALS MARKET, BY TYPE
6.1. Overview
6.1.1. Market Size and Forecast, By Type
6.2. Diagnostic
6.3. Therapeutic
Chapter 7: BRAZIL RADIOPHARMACEUTICALS MARKET, BY END USER
7.1. Overview
7.1.1. Market Size and Forecast, By End User
7.2. Hospitals and clinics
7.3. Medical Imaging centers
7.4. Others
Chapter 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
Chapter 9: COMPANY PROFILES
9.1. BRABCOOK Pharmaceuticals
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Crist?lia
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. AROMAR
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. National Radiopharmaceuticals
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Buclizine
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Anadigm
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. ALLERGAN Groups
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Gama Medica
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. FcSm
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. Zepp Online Laboratories
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments



List of Figures

LIST OF FIGURES
FIGURE 01. BRAZIL RADIOPHARMACEUTICALS MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF BRAZIL RADIOPHARMACEUTICALS MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN BRAZIL RADIOPHARMACEUTICALS MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: BRAZIL RADIOPHARMACEUTICALS MARKET
FIGURE 10. BRAZIL RADIOPHARMACEUTICALS MARKET,BY RADIOISOTOPE, 2022 ($MILLION)
FIGURE 11. BRAZIL RADIOPHARMACEUTICALS MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. BRAZIL RADIOPHARMACEUTICALS MARKET,BY TYPE, 2022 ($MILLION)
FIGURE 13. BRAZIL RADIOPHARMACEUTICALS MARKET,BY END USER, 2022 ($MILLION)
FIGURE 14. TOP WINNING STRATEGIES, BY YEAR
FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 18. COMPETITIVE DASHBOARD
FIGURE 19. COMPETITIVE HEATMAP: BRAZIL RADIOPHARMACEUTICALS MARKET
FIGURE 20. TOP PLAYER POSITIONING, 2022
FIGURE 21. BRABCOOK PHARMACEUTICALS: NET SALES, 2020-2022*?($MILLION)
FIGURE 22. BRABCOOK PHARMACEUTICALS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 23. BRABCOOK PHARMACEUTICALS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 24. CRIST?LIA: NET SALES, 2020-2022*?($MILLION)
FIGURE 25. CRIST?LIA: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 26. CRIST?LIA: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 27. AROMAR: NET SALES, 2020-2022*?($MILLION)
FIGURE 28. AROMAR: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 29. AROMAR: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 30. NATIONAL RADIOPHARMACEUTICALS: NET SALES, 2020-2022*?($MILLION)
FIGURE 31. NATIONAL RADIOPHARMACEUTICALS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 32. NATIONAL RADIOPHARMACEUTICALS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 33. BUCLIZINE: NET SALES, 2020-2022*?($MILLION)
FIGURE 34. BUCLIZINE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 35. BUCLIZINE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 36. ANADIGM: NET SALES, 2020-2022*?($MILLION)
FIGURE 37. ANADIGM: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 38. ANADIGM: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 39. ALLERGAN GROUPS: NET SALES, 2020-2022*?($MILLION)
FIGURE 40. ALLERGAN GROUPS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 41. ALLERGAN GROUPS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 42. GAMA MEDICA: NET SALES, 2020-2022*?($MILLION)
FIGURE 43. GAMA MEDICA: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 44. GAMA MEDICA: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 45. FCSM: NET SALES, 2020-2022*?($MILLION)
FIGURE 46. FCSM: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 47. FCSM: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 48. ZEPP ONLINE LABORATORIES: NET SALES, 2020-2022*?($MILLION)
FIGURE 49. ZEPP ONLINE LABORATORIES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 50. ZEPP ONLINE LABORATORIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

List of Tables

LIST OF TABLES
TABLE 01. BRAZIL RADIOPHARMACEUTICALS MARKET, BY RADIOISOTOPE, 2022-2032 ($MILLION)
TABLE 02. BRAZIL RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. BRAZIL RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 04. BRAZIL RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 05. BRABCOOK PHARMACEUTICALS: KEY EXECUTIVES
TABLE 06. BRABCOOK PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 07. BRABCOOK PHARMACEUTICALS: OPERATING SEGMENTS
TABLE 08. BRABCOOK PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 09. BRABCOOK PHARMACEUTICALS: KEY STRATERGIES
TABLE 10. CRIST?LIA: KEY EXECUTIVES
TABLE 11. CRIST?LIA: COMPANY SNAPSHOT
TABLE 12. CRIST?LIA: OPERATING SEGMENTS
TABLE 13. CRIST?LIA: PRODUCT PORTFOLIO
TABLE 14. CRIST?LIA: KEY STRATERGIES
TABLE 15. AROMAR: KEY EXECUTIVES
TABLE 16. AROMAR: COMPANY SNAPSHOT
TABLE 17. AROMAR: OPERATING SEGMENTS
TABLE 18. AROMAR: PRODUCT PORTFOLIO
TABLE 19. AROMAR: KEY STRATERGIES
TABLE 20. NATIONAL RADIOPHARMACEUTICALS: KEY EXECUTIVES
TABLE 21. NATIONAL RADIOPHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 22. NATIONAL RADIOPHARMACEUTICALS: OPERATING SEGMENTS
TABLE 23. NATIONAL RADIOPHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 24. NATIONAL RADIOPHARMACEUTICALS: KEY STRATERGIES
TABLE 25. BUCLIZINE: KEY EXECUTIVES
TABLE 26. BUCLIZINE: COMPANY SNAPSHOT
TABLE 27. BUCLIZINE: OPERATING SEGMENTS
TABLE 28. BUCLIZINE: PRODUCT PORTFOLIO
TABLE 29. BUCLIZINE: KEY STRATERGIES
TABLE 30. ANADIGM: KEY EXECUTIVES
TABLE 31. ANADIGM: COMPANY SNAPSHOT
TABLE 32. ANADIGM: OPERATING SEGMENTS
TABLE 33. ANADIGM: PRODUCT PORTFOLIO
TABLE 34. ANADIGM: KEY STRATERGIES
TABLE 35. ALLERGAN GROUPS: KEY EXECUTIVES
TABLE 36. ALLERGAN GROUPS: COMPANY SNAPSHOT
TABLE 37. ALLERGAN GROUPS: OPERATING SEGMENTS
TABLE 38. ALLERGAN GROUPS: PRODUCT PORTFOLIO
TABLE 39. ALLERGAN GROUPS: KEY STRATERGIES
TABLE 40. GAMA MEDICA: KEY EXECUTIVES
TABLE 41. GAMA MEDICA: COMPANY SNAPSHOT
TABLE 42. GAMA MEDICA: OPERATING SEGMENTS
TABLE 43. GAMA MEDICA: PRODUCT PORTFOLIO
TABLE 44. GAMA MEDICA: KEY STRATERGIES
TABLE 45. FCSM: KEY EXECUTIVES
TABLE 46. FCSM: COMPANY SNAPSHOT
TABLE 47. FCSM: OPERATING SEGMENTS
TABLE 48. FCSM: PRODUCT PORTFOLIO
TABLE 49. FCSM: KEY STRATERGIES
TABLE 50. ZEPP ONLINE LABORATORIES: KEY EXECUTIVES
TABLE 51. ZEPP ONLINE LABORATORIES: COMPANY SNAPSHOT
TABLE 52. ZEPP ONLINE LABORATORIES: OPERATING SEGMENTS
TABLE 53. ZEPP ONLINE LABORATORIES: PRODUCT PORTFOLIO
TABLE 54. ZEPP ONLINE LABORATORIES: KEY STRATERGIES